TWI329514B - One dose vaccination with mycoplasma hyopneumoniae - Google Patents

One dose vaccination with mycoplasma hyopneumoniae Download PDF

Info

Publication number
TWI329514B
TWI329514B TW091114057A TW91114057A TWI329514B TW I329514 B TWI329514 B TW I329514B TW 091114057 A TW091114057 A TW 091114057A TW 91114057 A TW91114057 A TW 91114057A TW I329514 B TWI329514 B TW I329514B
Authority
TW
Taiwan
Prior art keywords
pneumoniae
vaccine
porcine
pig
patent application
Prior art date
Application number
TW091114057A
Other languages
English (en)
Chinese (zh)
Inventor
Robin Lee Keich
Lisa Grace Sabbadini
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23168589&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TWI329514(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Application granted granted Critical
Publication of TWI329514B publication Critical patent/TWI329514B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/87—Mycoplasma

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW091114057A 2001-07-02 2002-06-26 One dose vaccination with mycoplasma hyopneumoniae TWI329514B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30263601P 2001-07-02 2001-07-02

Publications (1)

Publication Number Publication Date
TWI329514B true TWI329514B (en) 2010-09-01

Family

ID=23168589

Family Applications (1)

Application Number Title Priority Date Filing Date
TW091114057A TWI329514B (en) 2001-07-02 2002-06-26 One dose vaccination with mycoplasma hyopneumoniae

Country Status (42)

Country Link
US (3) US6846477B2 (enExample)
EP (3) EP2027873B8 (enExample)
JP (1) JP2005515162A (enExample)
KR (1) KR20040030785A (enExample)
CN (3) CN101524532B (enExample)
AP (1) AP2003002937A0 (enExample)
AR (1) AR034678A1 (enExample)
AT (1) ATE412426T2 (enExample)
AU (1) AU2002309109B2 (enExample)
BG (1) BG66481B1 (enExample)
BR (1) BR0210804A (enExample)
CA (1) CA2451626C (enExample)
CY (1) CY1108749T1 (enExample)
CZ (1) CZ305781B6 (enExample)
DE (1) DE60229666D1 (enExample)
DK (3) DK2842569T3 (enExample)
DO (1) DOP2002000431A (enExample)
EA (1) EA009901B1 (enExample)
ES (3) ES2550458T3 (enExample)
GT (1) GT200200138A (enExample)
HK (1) HK1207584A1 (enExample)
HR (1) HRP20031079A2 (enExample)
HU (1) HU230246B1 (enExample)
IL (1) IL159349A0 (enExample)
IS (1) IS7076A (enExample)
MA (1) MA27047A1 (enExample)
MX (1) MXPA03011599A (enExample)
NO (1) NO342654B1 (enExample)
NZ (1) NZ530106A (enExample)
OA (1) OA12638A (enExample)
PA (1) PA8549701A1 (enExample)
PE (1) PE20030285A1 (enExample)
PL (1) PL209773B1 (enExample)
PT (3) PT2842569T (enExample)
SK (1) SK288010B6 (enExample)
TN (1) TNSN03155A1 (enExample)
TW (1) TWI329514B (enExample)
UA (1) UA78707C2 (enExample)
UY (1) UY27366A1 (enExample)
WO (1) WO2003003941A2 (enExample)
YU (1) YU102203A (enExample)
ZA (1) ZA200309698B (enExample)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY129765A (en) * 2000-12-19 2007-04-30 Wyeth Corp Improved mycoplasma hyopneumoniae bacterin vaccine
WO2006056841A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Multiple-strain mycoplasma hyopneumoniae vaccines
US7700285B1 (en) 2005-12-29 2010-04-20 Boehringer Ingelheim Vetmedica, Inc. PCV2 immunogenic compositions and methods of producing such compositions
US7833707B2 (en) 2004-12-30 2010-11-16 Boehringer Ingelheim Vetmedica, Inc. Methods of overexpression and recovery of porcine circovirus type 2 ORF2
UA95602C2 (ru) 2004-12-30 2011-08-25 Берингер Ингельхейм Ветмедика, Инк. Иммуногенная композиция цвс2 и способы приготовления такой композиции
US8834891B2 (en) 2005-03-14 2014-09-16 Boehringer Ingelheim Vetmedica, Inc. Immunogenic compositions comprising Lawsonia intracellularis
ES2553254T3 (es) 2005-12-29 2015-12-07 Boehringer Ingelheim Vetmedica, Inc. Uso de una composición inmunogénica de PCV2 para reducir los síntomas clínicos en cerdos
CN102698263B (zh) 2005-12-29 2016-07-06 贝林格尔.英格海姆维特梅迪卡有限公司 多价pcv2免疫原性组合物和制备此类组合物的方法
BRPI0708522A2 (pt) * 2006-03-03 2011-05-31 Merial Ltd vacina de mycoplasma hyopneumoniae
EP2099927A4 (en) * 2006-11-22 2010-05-05 Boehringer Ingelheim Vetmed Methods of reducing porcine circovirus-associated disease outbreaks
EP2101815A4 (en) 2006-12-11 2010-10-06 Boehringer Ingelheim Vetmed Effective method of treatment of porcine circovirus and lawsonia intracellularis infections
RU2520087C2 (ru) 2006-12-15 2014-06-20 Бёрингер Ингельхайм Ветмедика, Инк. Лечение свиней с помощью антигена pcv2
EP1941903A1 (en) 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
EP1958644A1 (en) 2007-02-13 2008-08-20 Boehringer Ingelheim Vetmedica Gmbh Prevention and treatment of sub-clinical pcvd
US7829274B2 (en) 2007-09-04 2010-11-09 Boehringer Ingelheim Vetmedica, Inc. Reduction of concomitant infections in pigs by the use of PCV2 antigen
KR101225304B1 (ko) 2007-11-06 2013-01-22 와이어쓰 엘엘씨 마이코플라스마 하이오뉴모니아에 비독성 항원보강된 살아있는 백신
WO2009088950A2 (en) * 2007-12-31 2009-07-16 Boehringer Ingelheim Vetmedica, Inc. Pcv2 orf2 virus like particle with foreign amino acid insertion
CN101236206B (zh) * 2008-01-17 2014-10-15 中国兽医药品监察所 一种猪肺炎支原体重组抗原elisa检测试剂盒
EP2242511A4 (en) * 2008-01-23 2012-10-24 Boehringer Ingelheim Vetmed IMMUNOGENIC COMPOSITIONS OF MYCOPLASMA HYOPNEUMONIAE PCV2, AND METHODS FOR PRODUCING SUCH COMPOSITIONS
US8444989B1 (en) * 2008-04-18 2013-05-21 Boehringer Ingelheim Vetmedica Gmbh One dose vaccination against mycoplasma infections of pigs
EP3725328A3 (en) * 2008-06-27 2020-12-23 Zoetis Services LLC Novel adjuvant compositions
TWI583403B (zh) 2009-06-04 2017-05-21 國立感染症研究所 黴漿菌感染症用疫苗
AR078253A1 (es) 2009-09-02 2011-10-26 Boehringer Ingelheim Vetmed Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad
EP2550362B1 (en) 2010-03-25 2017-01-04 Oregon Health&Science University Cmv glycoproteins and recombinant vectors
ES2559445T3 (es) 2010-05-11 2016-02-12 Intervet International B.V. Vacuna contra Mycoplasma hyopneumoniae apta para la administración en presencia de anticuerpos de origen materno
RU2722357C2 (ru) * 2010-07-26 2020-05-29 Кью Байолоджикс Инк. Иммуногенные противовоспалительные композиции
US8546149B2 (en) 2010-08-27 2013-10-01 Intervet Inc. Potency test for vaccine formulations
HUE028877T2 (en) * 2010-08-27 2017-01-30 Intervet Int Bv Test of biological activity of vaccine formulation
RS57397B8 (sr) 2011-06-10 2020-01-31 Univ Oregon Health & Science Cmv glikoproteini i rekombinantni vektori
BR112014022067B1 (pt) * 2012-03-07 2022-05-31 Ceva Sante Animale Composição compreendendo antígeno e lipopolissacarídeo
US9120859B2 (en) 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
UA114503C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv та mycoplasma hyopneumoniae
UA121193C2 (uk) 2012-12-28 2020-04-27 Бьорінгер Інгельхайм Ветмедіка Гмбх Спосіб одержання імуногенної композиції проти мікоплазми
KR102355614B1 (ko) 2012-12-28 2022-01-27 베링거잉겔하임베트메디카게엠베하 마이코플라스마 항원을 포함하는 면역원성 조성물
MX355078B (es) * 2013-02-05 2018-04-03 Agricultural Tech Res Inst Vacuna de subunidades anti-mycoplasma spp.
CN104338125A (zh) * 2013-07-29 2015-02-11 普莱柯生物工程股份有限公司 一种猪肺炎支原体抗原在预防和治疗猪呼吸道疾病综合征方面的应用
WO2015042369A2 (en) 2013-09-19 2015-03-26 Zoetis Llc Oil-based adjuvants
MX373884B (es) 2013-10-02 2020-03-26 Boehringer Ingelheim Animal Health Usa Inc Variante de la proteína pcv2 orf2 y partículas similares al virus compuestas por ésta.
UA116697C2 (uk) * 2013-11-21 2018-04-25 Агрікалчерал Текнолоджи Рісьоч Інстітьют Композиція для запобігання зараженню видами роду mycoplasma
CN105012948B (zh) * 2014-04-18 2019-07-30 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
CN104248753B (zh) * 2014-05-15 2017-07-28 普莱柯生物工程股份有限公司 一种疫苗组合物及其应用
BR102014014727B1 (pt) * 2014-06-16 2018-04-03 Ouro Fino Saúde Animal Ltda COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, GENE SINTÉTICO CODIFICANTE DO COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae, COMPOSIÇÃO ANTIGÊNICA, PROCESSO DE OBTENÇÃO DE UM COMPLEXO DE POLIPROTEÍNAS IMUNOGÊNICAS DE M. hyopneumoniae
US9814769B2 (en) 2014-09-30 2017-11-14 Qatar University Vaccines against pathogenic Escherichia coli and methods of using the same
CN114699518B (zh) 2015-01-16 2024-07-02 硕腾服务有限责任公司 口蹄疫疫苗
KR20160099223A (ko) * 2015-02-12 2016-08-22 강원대학교산학협력단 마이코플라스마 하이오뉴모니애 박테린 백신 및 이의 제조방법
US10519199B2 (en) * 2016-08-12 2019-12-31 Innovac Vaccine composition comprising recombinant protein for preventing swine Mycoplasma infection
RU2668799C1 (ru) * 2017-09-08 2018-10-02 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
CN108101969A (zh) * 2017-11-13 2018-06-01 南京大爻网络科技有限公司 一种与猪支原体肺炎相关的抗原及其应用
RU2695679C1 (ru) * 2018-09-11 2019-07-25 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp.
RU2759427C2 (ru) * 2019-07-08 2021-11-12 Эгрикалчурал Текнолоджи Рисерч Инститьют Субъединичная вакцина против mycoplasma spp
CN117305192A (zh) * 2023-12-01 2023-12-29 北京瑞阳瑞泰生物科技有限公司 一种猪肺炎支原体rt02株、疫苗组合物及其应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0283840A3 (en) * 1987-03-26 1989-08-09 Ml Technology Ventures, L.P. Mycoplasma hyopneumoniae antigen and uses therefor
US5252328A (en) 1987-03-26 1993-10-12 Martin Marietta Energy Systems, Inc. Mycoplasma hyopneumoniae antigen and uses therefor
DE3881993T2 (de) 1987-09-18 1993-09-30 Akzo Nv Mycoplasma-Impfstoff.
HUT65827A (en) 1990-04-02 1994-07-28 Synergen Inc Polypeptides useful in animal treatment against mycoplasma infections
EP0597852B2 (en) 1990-05-29 2005-08-10 Wyeth Holdings Corporation Swine pneumonia vaccine and method for the preparation thereof
US6113916A (en) * 1990-05-29 2000-09-05 American Cyanamid Company Method of enhancing cell mediated immune responses
US5565205A (en) 1990-08-16 1996-10-15 Solvay Animal Health, Inc. Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof
EP0475185A1 (en) 1990-08-27 1992-03-18 Nippon Flour Mills Co., Ltd. DNA's encoding surface antigen of mycoplasma hyopneumoniae, DNA fragments for primer, recombinant antigenic peptides and diagnostic method of mycoplasmal pneumoniae of swine using same
US5338543A (en) * 1992-02-27 1994-08-16 Ambico, Inc. Thimerosal inactivated mycoplasma hyopneumoniae vaccine
AU687750B2 (en) * 1992-09-28 1998-03-05 Wyeth Holdings Corporation Method of enhancing cell mediated immune responses
US5530874A (en) 1993-02-02 1996-06-25 3Com Corporation Network adapter with an indication signal mask and an interrupt signal mask
WO1995009870A1 (en) 1993-10-07 1995-04-13 Iowa State University Research Foundation, Inc. Characterization of mycoplasma hyopneumoniae adhesins
ATE365049T1 (de) 1994-05-10 2007-07-15 Wyeth Corp Abgeänderter, verbesserter brsv lebend- impfstoff
US5788962A (en) 1995-01-17 1998-08-04 The Curators Of The University Of Missouri DNA sequences coding for mycoplasma hyopneumoniae surface antigens, corresponding proteins and use in vaccines and diagnostic procedures
AUPN178995A0 (en) * 1995-03-16 1995-04-13 University Of Melbourne, The Antigen composition
ES2224273T3 (es) 1996-09-30 2005-03-01 University Of Arkansas Metodo para producir inmunidad activa por medio de un conjugado de vacuna.
EP0846468B1 (en) 1996-12-05 2004-06-09 Akzo Nobel N.V. Non-virulent mycoplasma synoviae and vaccine thereof
KR20010032493A (ko) 1997-11-26 2001-04-25 아이오와 스테이트 유니버시티 리서치 파운데이션, 인코퍼레이티드 재조합 미코플라스마 히오뉴모니아(Ｍｙｃｏｐｌａｓｍａｈｙｏｐｎｅｕｍｏｎｉａｅ) 백신
AU6128900A (en) * 1999-09-29 2001-04-05 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
US6585981B1 (en) * 2000-07-27 2003-07-01 Regents Of The University Of Minnesota Temperature-sensitive live vaccine for Mycoplasma hyopneumoniae
UA114504C2 (uk) 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs

Also Published As

Publication number Publication date
US20030109473A1 (en) 2003-06-12
CZ20033466A3 (cs) 2005-06-15
SK288010B6 (sk) 2012-10-02
PA8549701A1 (es) 2003-01-24
DK1474067T3 (da) 2008-12-08
EP1474067A4 (en) 2005-08-10
CZ305781B6 (cs) 2016-03-16
WO2003003941A2 (en) 2003-01-16
EP2027873B8 (en) 2015-11-11
AP2003002937A0 (en) 2003-12-31
ZA200309698B (en) 2014-04-30
ATE412426T2 (de) 2008-11-15
NO342654B1 (no) 2018-06-25
HK1134900A1 (zh) 2010-05-20
CN1551781B (zh) 2013-01-02
PL373367A1 (en) 2005-08-22
EP2842569A1 (en) 2015-03-04
HK1180224A1 (zh) 2013-10-18
JP2005515162A (ja) 2005-05-26
KR20040030785A (ko) 2004-04-09
PT2027873E (pt) 2015-11-03
ES2550458T3 (es) 2015-11-10
BG66481B1 (bg) 2015-02-27
EP2027873B1 (en) 2015-09-09
MA27047A1 (fr) 2004-12-20
PT2842569T (pt) 2019-06-17
TNSN03155A1 (fr) 2005-12-23
PT1474067E (pt) 2008-11-14
CN101524532A (zh) 2009-09-09
YU102203A (sh) 2006-05-25
EP2842569B1 (en) 2019-04-10
DOP2002000431A (es) 2003-01-15
ES2312580T3 (es) 2009-03-01
CN102872456B (zh) 2016-01-20
HK1207584A1 (en) 2016-02-05
USRE44399E1 (en) 2013-07-30
EP1474067A2 (en) 2004-11-10
EP1474067B2 (en) 2017-08-16
AU2002309109B2 (en) 2007-12-13
NZ530106A (en) 2007-06-29
BG108546A (bg) 2005-02-28
IS7076A (is) 2003-12-15
CA2451626C (en) 2011-05-31
DK2027873T3 (en) 2015-11-09
CN102872456A (zh) 2013-01-16
EA200301323A1 (ru) 2005-06-30
GT200200138A (es) 2003-05-15
SK15792003A3 (sk) 2005-09-08
AR034678A1 (es) 2004-03-03
NO20035762L (no) 2004-02-02
DK2842569T3 (da) 2019-05-20
HRP20031079A2 (en) 2005-10-31
EP2027873A1 (en) 2009-02-25
UA78707C2 (en) 2007-04-25
PL209773B1 (pl) 2011-10-31
CN1551781A (zh) 2004-12-01
CA2451626A1 (en) 2003-01-16
US6846477B2 (en) 2005-01-25
BR0210804A (pt) 2005-05-03
CY1108749T1 (el) 2014-04-09
HK1068250A1 (en) 2005-04-29
CN101524532B (zh) 2014-03-19
EA009901B1 (ru) 2008-04-28
OA12638A (en) 2006-06-15
PE20030285A1 (es) 2003-03-27
US20050013823A1 (en) 2005-01-20
HUP0400434A2 (en) 2007-08-28
EP1474067B1 (en) 2008-10-29
WO2003003941A3 (en) 2004-07-29
DK1474067T4 (en) 2017-10-16
HU230246B1 (hu) 2015-11-30
MXPA03011599A (es) 2005-03-07
IL159349A0 (en) 2004-06-01
ES2729579T3 (es) 2019-11-04
UY27366A1 (es) 2003-04-30
DE60229666D1 (de) 2008-12-11
ES2312580T5 (es) 2017-12-11

Similar Documents

Publication Publication Date Title
TWI329514B (en) One dose vaccination with mycoplasma hyopneumoniae
AU2002309109A1 (en) One dose vaccination with mycoplasma hyopneumoniae
HK1134900B (en) One dose vaccination with (1) mycoplasma hyopneumoniae (/1)
HK1180224B (en) One dose vaccination with mycoplasma hyopneumoniae
HK1068250B (zh) 单剂量猪肺炎支原体疫苗

Legal Events

Date Code Title Description
MK4A Expiration of patent term of an invention patent